Barchart.com
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Menu
alerts false
Stocks | Futures | Watchlist | News | More
 
Advanced search
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:

Reshape Lifesciences Inc (RSLS)

Reshape Lifesciences Inc (RSLS)
0.4652 -0.1014 (-17.90%) 14:54 ET [NASDAQ]
0.4607 x 200 0.4681 x 200
Realtime by (Cboe BZX)
0.4607 x 200 0.4681 x 200
Realtime 0.5294 -0.0372 (-) 09:29 ET
News & Headlines for Fri, Apr 11th, 2025
Notes
Alerts
Watch
    Add or delete the symbol from one or more Watchlists.
  • Create New Watchlist
    This name already in use.
Help
Go To:
ReShape Lifesciences® Partners with Motion Informatics to Bring AI-Driven Neurorehabilitation Technology to the U.S. Market GlobeNewswire - Wed Apr 9, 3:05PM CDT

RSLS : 0.4652 (-17.90%)
ReShape Lifesciences® Reports Year Ended December 31, 2024 Financial Results and Provides Corporate Update GlobeNewswire - Mon Apr 7, 3:05PM CDT

RSLS : 0.4652 (-17.90%)
ReShape Lifesciences® Receives Notice of Allowance for U.S. Patent Related to Its Proprietary Diabetes Neuromodulation Technology GlobeNewswire - Mon Mar 10, 7:31AM CDT

RSLS : 0.4652 (-17.90%)
ReShape Lifesciences, Allarity, Exact Sciences, CVS, AbbVie: 5 Health Care Stocks That Led Retail Message Growth Last Week Stocktwits - Mon Mar 10, 12:56AM CDT

Speculation over an impending reverse merger, a Phase 2 trial announcement, comments about upcoming cancer screening tests, a Medicare business deal, and an obesity drug partnership sparked buzz among...

CVS : 69.81 (+1.22%)
EXAS : 43.67 (-0.16%)
ABBV : 176.38 (+1.25%)
RSLS : 0.4652 (-17.90%)
ALLR : 0.7040 (-2.91%)
ReShape Lifesciences® Signs Distribution Agreement in Canada With Liaison Medical for its Next-Generation Lap-Band® 2.0 FLEX GlobeNewswire - Tue Feb 25, 7:31AM CST

RSLS : 0.4652 (-17.90%)
ReShape Lifesciences® Announces Pricing of Upsized $6.0 Million Public Offering GlobeNewswire - Sat Feb 15, 10:17PM CST

RSLS : 0.4652 (-17.90%)
ReShape Lifesciences® Granted Key International Patent in Israel for Its Proprietary Diabetes Neuromodulation Technology GlobeNewswire - Mon Feb 3, 7:31AM CST

RSLS : 0.4652 (-17.90%)
ReShape Lifesciences® Provides Update on Merger Agreement With Vyome Therapeutics and Asset Purchase Agreement With Biorad Medisys GlobeNewswire - Mon Jan 13, 7:31AM CST

RSLS : 0.4652 (-17.90%)
ReShape Lifesciences® Reports Third Quarter Ended September 30, 2024 Financial Results and Provides Corporate Update GlobeNewswire - Thu Nov 14, 2024

RSLS : 0.4652 (-17.90%)
ReShape Lifesciences® to Announce Financial Results for the Third Quarter Ended September 30, 2024, and Provide Corporate Update GlobeNewswire - Tue Nov 12, 2024

RSLS : 0.4652 (-17.90%)

Barchart Exclusives

Should You Buy Tesla Stock on the ‘Liberation Day’ Dip? Barchart - 5 minutes ago
Down almost 50% from all-time highs, Tesla stock trades at a discount to price targets. But is TSLA stock a good buy? Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
UTC
Reserve Your Spot